Steffen Dietz
Has participated in:
-
Spatial and temporal heterogeneity of lung adenocarcinomas in tumor tissues and circulating DNA
-
Low input whole-exome sequencing to determine the representation of the tumor exome in circulating DNA of non-small cell lung cancer patients
-
Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis
-
Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy